Medicover AB (publ)
Medicover AB (publ) Fundamental Analysis
Medicover AB (publ) (MCVEF) shows moderate financial fundamentals with a PE ratio of 44.17, profit margin of 3.28%, and ROE of 15.50%. The company generates $2.4B in annual revenue with strong year-over-year growth of 13.69%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 37.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MCVEF's fundamental strength across five key dimensions:
Efficiency Score
WeakMCVEF struggles to generate sufficient returns from assets.
Valuation Score
ModerateMCVEF shows balanced valuation metrics.
Growth Score
ModerateMCVEF shows steady but slowing expansion.
Financial Health Score
WeakMCVEF carries high financial risk with limited liquidity.
Profitability Score
ModerateMCVEF maintains healthy but balanced margins.
Key Financial Metrics
Is MCVEF Expensive or Cheap?
P/E Ratio
MCVEF trades at 44.17 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, MCVEF's PEG of 0.31 indicates potential undervaluation.
Price to Book
The market values Medicover AB (publ) at 6.42 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 5.64 times EBITDA. This is generally considered low.
How Well Does MCVEF Make Money?
Net Profit Margin
For every $100 in sales, Medicover AB (publ) keeps $3.28 as profit after all expenses.
Operating Margin
Core operations generate 6.87 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.50 in profit for every $100 of shareholder equity.
ROA
Medicover AB (publ) generates $3.28 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Medicover AB (publ) produces operating cash flow of $318.77M, showing steady but balanced cash generation.
Free Cash Flow
Medicover AB (publ) produces free cash flow of $161.76M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.07 in free cash annually.
FCF Yield
MCVEF converts 4.60% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
44.17
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.31
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.42
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.45
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
2.60
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.74
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How MCVEF Stacks Against Its Sector Peers
| Metric | MCVEF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 44.17 | 29.43 | Worse (Expensive) |
| ROE | 15.50% | 684.00% | Weak |
| Net Margin | 3.28% | -45067.00% (disorted) | Weak |
| Debt/Equity | 2.60 | 0.43 | Weak (High Leverage) |
| Current Ratio | 0.74 | 4.07 | Weak Liquidity |
| ROA | 3.28% | -17158.00% (disorted) | Weak |
MCVEF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Medicover AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
124.17%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
182.53%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
107.23%
Industry Style: Defensive, Growth, Innovation
High Growth